Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "For the last 12 months, Rs 1,040 has been resistance for Infosys on the charts. So, the stock should be bought into once that resistance is crossed. It is not very far, 10-12 percent. I would feel that just entering into this trading range where it is bouncing will not give any results. I would wait patiently for that level if it is crossed and then only venture into it."
"The market is not giving a very comfortable impression to me and there are intraday buying opportunities in the Nifty, maybe swing trading, perhaps the view is on the downside. It is very confusing."
"Ajanta Pharma is a short sell. I think in pharmaceutical probably more lower levels are coming. The bear market in pharmaceutical is not over. When it is over it will become dream buy, but that is when it happens, not now."
"Balkrishna Industries which was an erstwhile high-flyer, is now distributing, giving a sense of a strong bear pattern and that could go much lower. It is a short sell," he said.
"IDFC Bank has done nothing. It is so easy to short it. Amongst so many other reasons, the charts are also weak."
"I have two buying ideas, Indraprastha Gas (IGL) had lifetime new highs two days ago, so, perhaps just a flat market could push it up. Colgate Palmolive had a nice correction, tells us we are buying on a dip," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
